scholarly journals PDB18 THE RELATIVE COST EFFECTIVENESS OF INSULIN GLARGINE VERSUS NPH INSULIN USING UK REAL LIFE DATA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

2007 ◽  
Vol 10 (3) ◽  
pp. A64-A65
Author(s):  
P McEwan ◽  
N Mehin ◽  
AP Tetlow ◽  
P Sharplin
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Real Life ◽  
Relative Cost ◽  
Nph Insulin ◽  
Life Data ◽  
Real Life Data

scholarly journals PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND

2010 ◽  
Vol 13 (7) ◽  
pp. A290 ◽  
Author(s):  
K Kolasa ◽  
M Niewada ◽  
J Puelles Fernandez de Troconiz ◽  
R Townsend ◽  
P McEwan
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Nph Insulin ◽  
The Cost

The Cost-Effectiveness of Saxagliptin Versus NPH Insulin When Used in Combination with Other Oral Antidiabetes Agents in the Treatment of Type 2 Diabetes Mellitus in Poland

2012 ◽  
Vol 14 (1) ◽  
pp. 65-73 ◽  
Author(s):  
Wladyslaw Grzeszczak ◽  
Leszek Czupryniak ◽  
Katarzyna Kolasa ◽  
Cezary Sciborski ◽  
Isabelle Duprat Lomon ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Nph Insulin ◽  
The Cost

Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis

2009 ◽  
Vol 25 (5) ◽  
pp. 1273-1284 ◽  
Author(s):  
Sandra L. Tunis ◽  
Michael E. Minshall ◽  
Christopher Conner ◽  
John I. McCormick ◽  
Jovana Kapor ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Insulin Detemir ◽  
Nph Insulin ◽  
Modeling Analysis
Sign in / Sign up

Export Citation Format

Share Document